International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 1017-1021 doi: 10.5281/zenodo.16936429
Research Article
Study of the Predictive Factors for First Trimester Bleeding in Pregnancy
 ,
 ,
 ,
Received
July 7, 2025
Accepted
Aug. 16, 2025
Published
Aug. 24, 2025
Abstract

Introduction: First trimester bleeding is a common obstetric complication, affecting up to 20–25% of all pregnancies. While not all cases result in adverse outcomes, such bleeding is often associated with increased risks of miscarriage, preterm labor, and placental complications later in pregnancy.

Aims and Objectives: To evaluate the clinical profile and ultrasonographic findings in pregnant women presenting with first trimester bleeding. To identify predictive factors associated with pregnancy outcomes in these cases.

Materials and methods: The present study was a Prospective study. This Study was conducted from December 2020 to July 2021 at Department of Obstetrics and Gynecology, Nilratan Sircar Medical College and Hospital, Kolkata. Total 60 patients were included in this study.

Result: The majority of participants were aged 21–25 years, with nearly half being primigravida. Abnormal USG findings were seen in 70%, most commonly retained products of conception. Mild bleeding was most frequent (55%), and 30% had a history of abortifacient use. Abortion was the most common outcome (61.67%), and bleeding was most frequent between 6–8 weeks. A significant association was found between bleeding severity and pregnancy outcome (p < 0.001), with all moderate and heavy bleeders resulting in abortion.

Conclusion: We concluded that the severity of first trimester bleeding emerged as a strong predictor of pregnancy outcomes. Women who experienced mild bleeding had a greater likelihood of continuing their pregnancies to term or preterm delivery, with a relatively lower risk of adverse outcomes.

Keywords
INTRODUCTION

First trimester bleeding is a common obstetric complication, affecting up to 20–25% of all pregnancies [1]. While not all cases result in adverse outcomes, such bleeding is often associated with increased risks of miscarriage, preterm labor, and placental complications later in pregnancy [2,3]. The etiology is multifactorial, including implantation bleeding, subchorionic hematoma, threatened abortion, ectopic pregnancy, and gestational trophoblastic disease. Identifying predictive factors such as maternal age, parity, prior miscarriages, assisted reproductive techniques, and lifestyle factors (e.g., smoking, alcohol use) can help in early risk stratification and targeted management [4]. Ultrasound and serum beta-hCG trends are essential tools in evaluating the prognosis of first trimester bleeding [5]. However, the predictive accuracy of clinical, biochemical, and ultrasonographic parameters remains inconsistent across different populations. Hence, this study aims to evaluate and analyze the predictive factors associated with first trimester bleeding in pregnancy to enhance early diagnosis and improve pregnancy outcomes.

 

MATERIALS AND METHODS

Study Type: Prospective study

Place Of Study: Department of Obstetrics and Gynecology, NILRATAN SIRCAR MEDICAL COLLEGE AND HOSPITAL, KOLKATA.

Period Of Study- December 2020 to July 2021

Study Population: Consenting Patients presenting with first trimester bleeding per vagina in OPD,emergency and indoor in the Department Of Obstetrics and Gynecology within the study period.

 

INCLUSION CRITERIA:

  1. Women with months of amenorrhea of <3
  2. Women with positive pregnancy
  3. Women with bleeding per vagina in first trimester of

 

EXCLUSION CRITERIA:

  1. Women with chronic medical complications including diabetes and hypertension
  2. Women with a history of infertility
  3. Women with bad obstetric history(h/o >3 first trimester abortion in previous pregnancy)
  4. Women with history of bleeding diathesis
  5. All patient with more than 12 completed weeks of gestation
  6. multiple gestations
  7. Molar

SAMPLE SIZE: we take 60 as minimal sample size for the study.

 

STUDY VARIABLES

  • Age
  • Parity
  • Socioeconomic status
  • Period of gestation
  • History of previous abortion.
  • Presentation
  • Duration of bleeding
  • Type of bleeding
  • Ultrasonography examination
  • Blood examination
  • General examination and Obstetrical examination

 

Statistical Analysis:-

For statistical analysis, data were initially entered into a Microsoft Excel spreadsheet and then analyzed using SPSS (version 27.0; SPSS Inc., Chicago, IL, USA) and GraphPad Prism (version 5). Numerical variables were summarized using means and standard deviations, while Data were entered into Excel and analyzed using SPSS and GraphPad Prism. Numerical variables were summarized using means and standard deviations, while categorical variables were described with counts and percentages. Two-sample t-tests were used to compare independent groups, while paired t-tests accounted for correlations in paired data. Chi-square tests (including Fisher’s exact test for small sample sizes) were used for categorical data comparisons. P-values ≤ 0.05 were considered statistically significant.

 

RESULT

Table 1. Distribution of cases according to the age groups

AGE

N

%

<20 years

8

13.33

21-25 years

35

58.33

26-30 years

16

26.67

>30 years

1

1.67

Total

60

100

Mean age (years)

23.2±3.6

 

 

 

Table 2. Clinical and Obstetric Profile of Patients Presenting with First Trimester Bleeding

Gravida

 

N

%

Primi

29

48.33

Multi

31

51.67

Total

60

100

USG Findings

Within normal limit

18

30

Abnormal

42

70

Total

60

100

Abnormal USG Findings

Blighted Ovum

1

2.38

C.A Absent

5

11.9

Ectopic Pregnancy

2

4.76

Missed Abortion

5

11.9

No Fetal Pole

3

7.14

Placenta Previa

2

4.76

RPOC

21

50

Subchorionic Hematoma

3

7.14

Bleeding

Mild(spotting)

33

55

Moderate

18

30

Heavy

9

15

Total

60

100

USE of Abortifacient

Yes

18

30

No

42

70

Total

60

100

Mode of Delivery

Vaginal delivery

15

71.43

LSCS

6

28.57

Total

21

100

Gestational Age At Bleeding

6-8 weeks

34

56.67

9-10 weeks

20

33.33

11-12 weeks

6

10

Total

60

100

Past Obstetric History

Spontaneous abortion

8

22.86

MTP

9

25.71

LSCS

8

22.86

Vaginal delivery

10

28.57

Outcome

Abortion

37

61.67

Laparotomy

2

3.33

Delivery at term

7

11.67

Delivery at preterm

14

23.33

Total

60

100

Previous abortion

A0

41

68.33

A1

13

21.67

A2

6

10

Total

60

100

 

Table 3. Comparison of outcome between different severities of bleeding

 

 

Moderate

Heavy

P value

OUTCOME

    Mild bleeding

bleeding

bleeding

 

N

%

N

%

N

%

Abortion

10

30.31

18

100

9

100

<0.001*

Laparotomy

2

6.06

0

0

0

0

Delivery at term

7

21.21

0

0

0

0

Delivery at preterm

14

42.42

0

0

0

0

Total

33

100

18

100

9

100

 

Figure 1: Distribution of cases according to the age groups

 

In our study, the majority of participants were in the age group of 21–25 years, accounting for 58.33% (n=35) of the total sample. This was followed by 26–30 years with 26.67% (n=16), and <20 years with 13.33% (n=8). Only 1.67% (n=1) of the participants were aged above 30 years. The mean age of the study population was 23.2 ± 3.6 years.

 

In our study, nearly half of the participants were primigravida (48.33%, n=29), while the remaining 51.67% (n=31) were multigravida. Ultrasonographic (USG) evaluation revealed abnormal findings in 70% (n=42) of cases, with only 30% (n=18) showing normal scans. Among the abnormal USG findings, retained products of conception (RPOC) was the most common (50%, n=21), followed by missed abortion and cardiac activity (C.A) absent (11.9% each, n=5), no fetal pole and subchorionic hematoma (7.14% each, n=3), and ectopic pregnancy and placenta previa (4.76% each, n=2). Blighted ovum was observed in 2.38% (n=1) of the cases. With regard to bleeding severity, mild spotting was most common (55%, n=33), followed by moderate (30%, n=18) and heavy bleeding (15%, n=9). A history of abortifacient use was reported in 30% (n=18) of the patients. Among those who continued their pregnancy and delivered (n=21), 71.43% (n=15) underwent vaginal delivery, while 28.57% (n=6) required lower segment cesarean section (LSCS). Bleeding most commonly occurred between 6 to 8 weeks of gestation (56.67%, n=34), followed by 9 to 10 weeks (33.33%, n=20), and 11 to 12 weeks (10%, n=6). Regarding past obstetric history (n=35), vaginal delivery was noted in 28.57% (n=10), medical termination of pregnancy (MTP) in 25.71% (n=9), spontaneous abortion and LSCS each in 22.86% (n=8). In terms of outcomes, abortion was the most frequent (61.67%, n=37), followed by preterm delivery (23.33%, n=14), term delivery (11.67%, n=7), and laparotomy (3.33%, n=2). Previous abortion history revealed that 68.33% (n=41) of the participants had no prior abortion (A0), while 21.67% (n=13) had one (A1), and 10% (n=6) had two previous abortions (A2).

 

In our study, bleeding severity was found to have a statistically significant association with pregnancy outcomes (p < 0.001). Among those with mild bleeding (n=33), 30.31% (n=10) had an abortion, 42.42% (n=14) delivered preterm, and 21.21% (n=7) delivered at term. Two patients (6.06%) in this group underwent laparotomy. In contrast, all patients with moderate (n=18) and heavy bleeding (n=9) experienced abortion, accounting for 100% of outcomes in both groups. No term or preterm deliveries and no laparotomies were reported in these groups. The difference in outcomes across bleeding severity was highly significant (p < 0.001), indicating a strong correlation between increased bleeding severity and risk of abortion.

 

DISCUSSION

In our study, the majority of women presenting with first trimester bleeding were in the 21–25-year age group, with a mean age of 23.2 ± 3.6 years. This aligns with findings from Victory J et al. (2021), who reported that first trimester bleeding is most prevalent among women in their early reproductive years [6]. Parity did not show a significant difference, with primigravida and multigravida almost equally represented, similar to the results of the study by SEDEF AM et al. (2015), which noted no significant difference in the incidence of early bleeding between primigravida and multigravida women [7]. Abnormal ultrasonographic findings were observed in 70% of our participants, with retained products of conception (RPOC) being the most common diagnosis. This is comparable to the findings of Gupte AN et al. (2021), who identified RPOC as a major ultrasonographic abnormality in women with first trimester bleeding [8]. Other findings in our study included missed abortion, absent cardiac activity, ectopic pregnancy, and subchorionic hematoma. In our study, the timing of bleeding was most common between 6 to 8 weeks of gestation, a pattern that correlates with the findings of Sapra et al. (2016), who reported the highest frequency of early pregnancy bleeding within this gestational window [9]. Importantly, we observed a significant association between bleeding severity and adverse pregnancy outcomes (p < 0.001). All women with moderate or heavy bleeding experienced abortion, whereas mild bleeding was associated with a more favorable prognosis, including preterm and term deliveries. The majority of adverse outcomes in our cohort were abortions (61.67%), followed by preterm deliveries. These findings reflect those of Thomas OK et al. (2021), who identified first trimester bleeding as a major predictor of both miscarriage and preterm birth in Indian populations [10]. Furthermore, our data suggest that previous abortion history plays a role in pregnancy outcomes. Women with one or more prior abortions had a higher likelihood of poor outcomes in the current pregnancy, consistent with the findings of Séjourné N et al. (2020), who reported increased risk of miscarriage in women with previous abortion history [11]. Thus, our findings reinforce the importance of early clinical evaluation, risk stratification using sonographic and clinical parameters, and close follow-up in cases of first trimester bleeding. The significant correlation between bleeding severity and pregnancy loss emphasizes the need for improved antenatal surveillance and patient education to mitigate risks.

CONCLUSION

We concluded that the severity of first trimester bleeding emerged as a strong predictor of pregnancy outcomes. Women who experienced mild bleeding had a greater likelihood of continuing their pregnancies to term or preterm delivery, with a relatively lower risk of adverse outcomes. In contrast, moderate to heavy bleeding was consistently associated with unfavorable outcomes, particularly spontaneous abortion, underscoring the prognostic significance of bleeding intensity. These findings highlight the importance of early evaluation and close monitoring of bleeding episodes during the first trimester to facilitate timely intervention and improve maternal-fetal outcomes.

REFERENCES
1. Everett C. Incidence and outcome of bleeding before the 20th week of pregnancy: prospective study from general practice. BMJ. 1997 Jul 5;315(7099):32-4. 2. Saraswat L, Bhattacharya S, Maheshwari A, Bhattacharya S. Maternal and perinatal outcome in women with threatened miscarriage in the first trimester: a systematic review. BJOG. 2010 Feb;117(3):245-57. 3. Weiss JL, Malone FD, Vidaver J, Ball RH, Nyberg DA, Comstock CH, Hankins GD, Berkowitz RL, Gross SJ, Dugoff L, Timor-Tritsch IE. Threatened abortion: a risk factor for poor pregnancy outcome, a population-based screening study. Am J Obstet Gynecol. 2004 Mar 1;190(3):745-50. 4. Hasan R, Baird DD, Herring AH, Olshan AF, Funk ML, Hartmann KE. Association between first-trimester vaginal bleeding and miscarriage. Obstet Gynecol. 2009 Oct 1;114(4):860-7. 5. Murugesu S, Braun E, Saso S, Bourne T. Predictors of successful expectant and medical management of miscarriage: A systematic review. Acta Obstet Gynecol Scand. 2024 Dec;103(12):2348-72. 6. Victory J. Examining the association between in-vitro fertilization and severe maternal morbidity in the United States and Canada [dissertation]. University of British Columbia; 202X. 7. SEDEF AM, editor. Gebelikte Onkolojik Yaklaşımlar. Akademisyen Kitabevi; 2021 May 31. Amini L, Foroozanfard F, Saghafi N, Bazarganipour F. Association between early pregnancy bleeding and pregnancy outcome: A prospective study. J Obstet Gynaecol Res. 2021;47(1):103-10. 8. Gupte AN. RESPIRATORY IMPAIRMENT IN TUBERCULOSIS AND HIV (RESPITH): TRENDS, PREDICTORS AND IMPLICATIONS [dissertation]. Johns Hopkins University; 202X. 9. Sapra KJ, Buck Louis GM, Sundaram R, Joseph KS, Bates LM, Galea S, Ananth CV. Signs and symptoms associated with early pregnancy loss: findings from a population-based preconception cohort. Hum Reprod. 2016 Apr 1;31(4):887-96. 10. Thomas OK, Guleri R, Baria SS. Proceedings of ‘FETP-ICON 2020’ Conference. BMC Proc. 2021;15(Suppl 11):A1. 11. Séjourné N, Goutaudier N. Miscarriage and pregnancy loss. In: Handbook of Perinatal Clinical Psychology. Routledge; 2020 Mar 26. p. 103-31.
Recommended Articles
Research Article
The Cumulative Burden: A Case of Alcoholic Liver Disease, HIV, And Laryngeal Carcinoma in Chronic Substance Abuse
...
Published: 24/08/2025
Case Report
Nature’s Error…In Mirror He or She…Swyers Syndrome - A Rare Case
...
Published: 25/08/2025
Research Article
A Clinical Study of Acceptability & Safety of PPIUCD and Interval IUCD In RMC , Ajmer (Rajsthan)
...
Published: 25/08/2025
Research Article
Knowledge and Practice of Breastfeeding and Complementary Feeding Among Mothers of Under One Year Age Children
Published: 25/08/2025
Loading Image...
Volume-6, Issue-4
Citations
25 Views
17 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved